Naoya Inoue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Naoya Inoue has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Shuji Morikawa
Department of Cardiology Chutoen General Medical Center Kakegawa Shizuoka Japan
21 shared publicationsToyoaki Murohara
Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan (Inoue, Morikawa, and Murohara)
8 shared publicationsRyo Ohinata
Department of Cardiology, Chutoen General Medical Center
6 shared publicationsTakashi Ogane
Department of Cardiology Chutoen General Medical Center, Kakegawa Shizuoka Japan
6 shared publicationsTakehiro Hiramatsu
Department of Cardiology, Chutoen General Medical Center, Kakegawa, Shizuoka, Japan
6 shared publicationsTakashi Mishina
Department of Cardiology, Chutoen General Medical Center
4 shared publications
Latest Publications
- 12 September 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Left Bundle Branch Capture During Left Bundle Branch Area Pacing: A Diagnostic Accuracy Systematic Review
Background: Left bundle branch area pacing (LBBAP) does not necessarily achieve true left bundle branch (LBB) capture, and misclassifying left ventricular septal pacing (LVSP) as LBB capture may bias procedural decisions and outcome interpretation. We evaluated the diagnostic accuracy of electrocardiographic (ECG) and electrophysiological criteria for confirming true LBB capture and distinguishing it from LVSP or deep septal pacing. Methods: Following PRISMA‐DTA, we searched PubMed/MEDLINE, CENTRAL, the Cochrane Database of Systematic Reviews, and Google Scholar from inception to July 8, 2026. Eligible studies evaluated V6 R‐wave peak time (V6RWPT), V6–V1 interpeak interval, aVL R‐wave peak time, morphologic criteria, combined ECG criteria, or ECG/electrogram algorithms against a stated reference standard. Risk of bias was assessed with QUADAS‐2, emphasizing circularity. Results: Of 332 records, 15 original studies were included; eight formed the primary diagnostic accuracy evidence set, of which four provided extractable criterion‐level 2 × 2 data for exploratory pooling. The V6–V1 interpeak interval and combined ECG criteria showed the most consistent rule‐in performance, whereas fixed V6RWPT thresholds were susceptible to baseline conduction disease and pacing‐site variability. ECG and electrogram (EGM) stepwise algorithms achieved the highest specificity but had limited applicability owing to heterogeneous reference standards. Conclusions: The evidence supports a stepwise approach rather than any single ECG cutoff. High‐specificity ECG criteria aid rule‐in confirmation, whereas dynamic output‐dependent transitions and EGM‐based adjudication remain essential when ECG criteria are equivocal. Standardized definitions and reference standards are needed for future LBBAP trials.
- 12 September 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
Left Bundle Branch Capture During Left Bundle Branch Area Pacing: A Diagnostic Accuracy Systematic Review
Background: Left bundle branch area pacing (LBBAP) does not necessarily achieve true left bundle branch (LBB) capture, and misclassifying left ventricular septal pacing (LVSP) as LBB capture may bias procedural decisions and outcome interpretation. We evaluated the diagnostic accuracy of electrocardiographic (ECG) and electrophysiological criteria for confirming true LBB capture and distinguishing it from LVSP or deep septal pacing. Methods: Following PRISMA‐DTA, we searched PubMed/MEDLINE, CENTRAL, the Cochrane Database of Systematic Reviews, and Google Scholar from inception to July 8, 2026. Eligible studies evaluated V6 R‐wave peak time (V6RWPT), V6–V1 interpeak interval, aVL R‐wave peak time, morphologic criteria, combined ECG criteria, or ECG/electrogram algorithms against a stated reference standard. Risk of bias was assessed with QUADAS‐2, emphasizing circularity. Results: Of 332 records, 15 original studies were included; eight formed the primary diagnostic accuracy evidence set, of which four provided extractable criterion‐level 2 × 2 data for exploratory pooling. The V6–V1 interpeak interval and combined ECG criteria showed the most consistent rule‐in performance, whereas fixed V6RWPT thresholds were susceptible to baseline conduction disease and pacing‐site variability. ECG and electrogram (EGM) stepwise algorithms achieved the highest specificity but had limited applicability owing to heterogeneous reference standards. Conclusions: The evidence supports a stepwise approach rather than any single ECG cutoff. High‐specificity ECG criteria aid rule‐in confirmation, whereas dynamic output‐dependent transitions and EGM‐based adjudication remain essential when ECG criteria are equivocal. Standardized definitions and reference standards are needed for future LBBAP trials.
- Open Access
- 10 August 2026
- Published by Japanese Circulation Society in Circulation Reports
- Vol. 8 (8) , 1308-1316
Cumulative Atherogenic Index of Plasma Burden and Risk of Non-Fatal Myocardial Infarction and Ischemic Stroke Beyond Cumulative Low-Density Lipoprotein Cholesterol Burden
Background: A higher atherogenic index of plasma (AIP; calculated as log10[triglycerides/high-density lipoprotein cholesterol]) is an indicator of atherogenic dyslipidemia. Whether the cumulative AIP (cAIP) burden provides prognostic information beyond the cumulative low-density lipoprotein cholesterol (cLDL-C) burden remains unclear.Methods and Results: This retrospective study analyzed data for 11,402 adults with at least 3 health checkups. cAIP and cLDL-C burdens were calculated from the first 3 lipid-complete visits, with the third visit defined as the index date. The primary outcome was first non-fatal myocardial infarction (MI) or ischemic stroke. Cox models were adjusted for conventional cardiovascular risk factors and cLDL-C burden. Over a mean follow-up of 4.96 years, 435 primary events occurred. Per 1-SD increase, cAIP burden was independently associated with the primary outcome after full adjustment including cLDL-C burden (hazard ratio 1.14; 95% confidence interval 1.02–1.27). Restricted cubic splines showed a progressive increase in risk with higher AIP burden. In discordance analysis, low cLDL-C/high cAIP burden, but not high cLDL-C/low cAIP burden, was associated with a higher risk than low cLDL-C/low cAIP burden (hazard ratio 1.40; 95% confidence interval 1.04–1.89). The addition of AIP burden did not improve global discrimination or reclassification.Conclusions: cAIP burden was associated with incident non-fatal MI or ischemic stroke and identified excess risk despite low cLDL-C burden, supporting its complementary value for characterizing residual lipid-related risk.
- 10 August 2026
- Published by Japanese Circulation Society in Circulation Reports
- Vol. 8 (8) , 1308-1316
Open AccessCumulative Atherogenic Index of Plasma Burden and Risk of Non-Fatal Myocardial Infarction and Ischemic Stroke Beyond Cumulative Low-Density Lipoprotein Cholesterol Burden
Background: A higher atherogenic index of plasma (AIP; calculated as log10[triglycerides/high-density lipoprotein cholesterol]) is an indicator of atherogenic dyslipidemia. Whether the cumulative AIP (cAIP) burden provides prognostic information beyond the cumulative low-density lipoprotein cholesterol (cLDL-C) burden remains unclear.Methods and Results: This retrospective study analyzed data for 11,402 adults with at least 3 health checkups. cAIP and cLDL-C burdens were calculated from the first 3 lipid-complete visits, with the third visit defined as the index date. The primary outcome was first non-fatal myocardial infarction (MI) or ischemic stroke. Cox models were adjusted for conventional cardiovascular risk factors and cLDL-C burden. Over a mean follow-up of 4.96 years, 435 primary events occurred. Per 1-SD increase, cAIP burden was independently associated with the primary outcome after full adjustment including cLDL-C burden (hazard ratio 1.14; 95% confidence interval 1.02–1.27). Restricted cubic splines showed a progressive increase in risk with higher AIP burden. In discordance analysis, low cLDL-C/high cAIP burden, but not high cLDL-C/low cAIP burden, was associated with a higher risk than low cLDL-C/low cAIP burden (hazard ratio 1.40; 95% confidence interval 1.04–1.89). The addition of AIP burden did not improve global discrimination or reclassification.Conclusions: cAIP burden was associated with incident non-fatal MI or ischemic stroke and identified excess risk despite low cLDL-C burden, supporting its complementary value for characterizing residual lipid-related risk.
- 8 June 2026
- Published by Elsevier in Journal of Cardiology
- Vol. 88 (3) , 197-204
Mathematical analysis of the breakdown of physiological stability preceding heart failure onset using longitudinal health check-up data
- 8 June 2026
- Published by Elsevier in Journal of Cardiology
- Vol. 88 (3) , 197-204
Mathematical analysis of the breakdown of physiological stability preceding heart failure onset using longitudinal health check-up data
- 5 May 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (7) , 1367-1376
Multidimensional lipid phenotyping for stratification of residual cardiovascular risk: A focus on fatty acid balance
- 5 May 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (7) , 1367-1376
Multidimensional lipid phenotyping for stratification of residual cardiovascular risk: A focus on fatty acid balance
- 11 April 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (6) , 1230-1240
Left Atrial Remodeling After Pacemaker Implantation Predicts Incident Atrial Fibrillation: Comparison of Leadless and Transvenous Devices
Background: Atrial fibrillation (AF) after pacemaker (PM) implantation is associated with adverse outcomes; however, the relationship between left atrial remodeling, device type, and ventricular pacing burden remains unclear. Objective: We aimed to investigate (1) whether post‐implantation changes in left atrial diameter (ΔLAD) are associated with incident AF; (2) differences in AF and ΔLAD between TVP and LP; and (3) whether mean ventricular pacing percentage (Vp%) modifies device‐related effects. Methods: This retrospective study included patients without a prior history of AF who underwent PM implantation. The primary outcome was defined as incident clinical AF, which was analyzed using Cox hazard models. Mechanistic models incorporating Vp% and paced QRS duration were also evaluated. Interaction analyses were performed using mean‐centered Vp % (device × Vp) and Vp%‐stratified analyses. To mitigate reverse causality, a landmark analysis excluding AF events within 1 year after implantation was conducted. Results: In the pooled Cox analyses, ΔLAD was independently associated with incident AF ( p < 0.0001). No significant difference in ΔLAD was observed between the TVP and LP groups ( p = 0.417). In models adjusted for ΔLAD, LP was associated with a significantly lower risk of AF (device, p = 0.049; ΔLAD, p < 0.0001). Vp% and paced QRS duration were not significant main effects. However, a significant device × Vp interaction was observed in the mean‐centered interaction models ( p = 0.022). In landmark analyses, ΔLAD remained associated with AF beyond 1 year ( p = 0.0013). Conclusion: Left atrial remodeling independently predicted incident AF after pacemaker implantation. LP was associated with a lower AF risk, with effects modified by the pacing burden.
- 11 April 2026
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (6) , 1230-1240
Left Atrial Remodeling After Pacemaker Implantation Predicts Incident Atrial Fibrillation: Comparison of Leadless and Transvenous Devices
Background: Atrial fibrillation (AF) after pacemaker (PM) implantation is associated with adverse outcomes; however, the relationship between left atrial remodeling, device type, and ventricular pacing burden remains unclear. Objective: We aimed to investigate (1) whether post‐implantation changes in left atrial diameter (ΔLAD) are associated with incident AF; (2) differences in AF and ΔLAD between TVP and LP; and (3) whether mean ventricular pacing percentage (Vp%) modifies device‐related effects. Methods: This retrospective study included patients without a prior history of AF who underwent PM implantation. The primary outcome was defined as incident clinical AF, which was analyzed using Cox hazard models. Mechanistic models incorporating Vp% and paced QRS duration were also evaluated. Interaction analyses were performed using mean‐centered Vp % (device × Vp) and Vp%‐stratified analyses. To mitigate reverse causality, a landmark analysis excluding AF events within 1 year after implantation was conducted. Results: In the pooled Cox analyses, ΔLAD was independently associated with incident AF ( p < 0.0001). No significant difference in ΔLAD was observed between the TVP and LP groups ( p = 0.417). In models adjusted for ΔLAD, LP was associated with a significantly lower risk of AF (device, p = 0.049; ΔLAD, p < 0.0001). Vp% and paced QRS duration were not significant main effects. However, a significant device × Vp interaction was observed in the mean‐centered interaction models ( p = 0.022). In landmark analyses, ΔLAD remained associated with AF beyond 1 year ( p = 0.0013). Conclusion: Left atrial remodeling independently predicted incident AF after pacemaker implantation. LP was associated with a lower AF risk, with effects modified by the pacing burden.
- 28 February 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 267, 72-79
Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure With Supra-Normal Ejection Fraction: A Target Trial Emulation Study
- 28 February 2026
- Published by Elsevier in The American Journal of Cardiology
- Vol. 267, 72-79
Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure With Supra-Normal Ejection Fraction: A Target Trial Emulation Study
- 4 December 2025
- Published by Elsevier in Heart Rhythm
- Vol. 23 (4) , e605-e614
Temporal change in right ventricular pacing ratio and its association with cardiac function and arrhythmia: A linear mixed-effects model analysis
- 4 December 2025
- Published by Elsevier in Heart Rhythm
- Vol. 23 (4) , e605-e614
Temporal change in right ventricular pacing ratio and its association with cardiac function and arrhythmia: A linear mixed-effects model analysis
- Open Access
- 21 March 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (6) , 789-798
Evaluation of cardiac energetics in left bundle branch area pacing using noninvasive pressure–volume loops
- 21 March 2025
- Published by Elsevier in Heart Rhythm O2
- Vol. 6 (6) , 789-798
Open AccessEvaluation of cardiac energetics in left bundle branch area pacing using noninvasive pressure–volume loops
- Open Access
- 22 January 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (2) , ytaf022
Evaluation of right ventricular pacing-induced coronary microvascular dysfunction using guide wire-based sensor technology: a case report
Background: The diagnosis of ischaemic non-obstructive coronary artery disease is crucial for the differential diagnosis of chest pain. However, the pathophysiology of chest pain and evaluation of coronary microcirculation in patients with right ventricular pacing (RVP) have not been sufficiently reported. Case summary: The patient was a 53-year-old woman who underwent dual-chamber pacemaker implantation because of sinus node dysfunction. She experienced chest pain before pacemaker implantation; however, the frequency and severity of her chest pain increased after the implantation. She was referred for the evaluation of coronary microvascular dysfunction (CMD). Coronary angiography revealed no significant stenosis of the epicardial vessels. Subsequent evaluation of CMD showed that while the index of microcirculatory resistance [normalized index of microcirculatory resistance (IMR)] in the left anterior descending artery (LAD) was 19 U during the native rhythm, an increase in IMR (normalized IMR: 27 U) was observed during RVP. Discussion: Right ventricular pacing may not only induce left ventricular dyssynchrony due to non-physiological excitation propagation but may also provoke CMD in the LAD territory, particularly in the septal branches, which could contribute to pacing-induced structural CMD and chest pain. However, RVP may well be a contributing but not exclusively a factor of CMD.
- 22 January 2025
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 9 (2) , ytaf022
Open AccessEvaluation of right ventricular pacing-induced coronary microvascular dysfunction using guide wire-based sensor technology: a case report
Background: The diagnosis of ischaemic non-obstructive coronary artery disease is crucial for the differential diagnosis of chest pain. However, the pathophysiology of chest pain and evaluation of coronary microcirculation in patients with right ventricular pacing (RVP) have not been sufficiently reported. Case summary: The patient was a 53-year-old woman who underwent dual-chamber pacemaker implantation because of sinus node dysfunction. She experienced chest pain before pacemaker implantation; however, the frequency and severity of her chest pain increased after the implantation. She was referred for the evaluation of coronary microvascular dysfunction (CMD). Coronary angiography revealed no significant stenosis of the epicardial vessels. Subsequent evaluation of CMD showed that while the index of microcirculatory resistance [normalized index of microcirculatory resistance (IMR)] in the left anterior descending artery (LAD) was 19 U during the native rhythm, an increase in IMR (normalized IMR: 27 U) was observed during RVP. Discussion: Right ventricular pacing may not only induce left ventricular dyssynchrony due to non-physiological excitation propagation but may also provoke CMD in the LAD territory, particularly in the septal branches, which could contribute to pacing-induced structural CMD and chest pain. However, RVP may well be a contributing but not exclusively a factor of CMD.
- Open Access
- 26 December 2024
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (1) , e13208
Assessment of adverse events stratified by timing of leadless pacemaker implantation with cardiac implantable electronic devices extraction due to infection: A systematic review and meta‐analysis
Background: Removal of cardiac implantable electronic devices (CIEDs) is strongly recommended for CIED‐related infections, and leadless pacemakers (LPs) are increasingly used for reimplantation. However, the optimal timing and safety of LP implantation after CIED removal for infection remains unclear. This systematic review and meta‐analysis aimed to assess complication rates (all‐cause mortality and reinfection) when LP implantation was performed simultaneously with or after CIED removal. Methods: Studies published from 2015 to September 2024 were searched in PubMed, Cochrane Library, and Google Scholar. Observational studies and case series on CIED removal and LP implantation were eligible. The primary outcomes were all‐cause mortality and reinfection post‐LP implantation. Pooled estimates were obtained using the Freedman‐Tukey double arcsine transformation. Study quality was assessed using the MINORS criteria, with data extraction and independent assessment by two authors. Results: Of 396 records, 16 studies were included in the analysis, with 653 patients (mean age:76.9 years). The incidence of isolated pocket infections was 46.7% (95% CI: 32.7%–61.2%) and systemic infections at 46.3% (95% CI: 29.5%–64.0%). The primary outcome incidence was 19.4% (95% CI: 12.8%–28.3%, I 2 : 0%) for simultaneous CIED extraction and LP implantation compared with 7.79% (4.37%–13.5%, I 2 : 4%) for LP implantation after CIED extraction ( p = .009). All‐cause mortality rates were 22.8% (95% CI: 15.9%–31.6%, I 2 : 0%) for simultaneous implantation and 8.71% (4.46%–16.3%, I 2 : 21%) after extraction ( p = 0.008). Reinfection was not observed in any of these studies. Conclusion: Simultaneous CIED extraction and LP implantation due to infection may be associated with an increased risk of all‐cause mortality.
- 26 December 2024
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (1) , e13208
Open AccessAssessment of adverse events stratified by timing of leadless pacemaker implantation with cardiac implantable electronic devices extraction due to infection: A systematic review and meta‐analysis
Background: Removal of cardiac implantable electronic devices (CIEDs) is strongly recommended for CIED‐related infections, and leadless pacemakers (LPs) are increasingly used for reimplantation. However, the optimal timing and safety of LP implantation after CIED removal for infection remains unclear. This systematic review and meta‐analysis aimed to assess complication rates (all‐cause mortality and reinfection) when LP implantation was performed simultaneously with or after CIED removal. Methods: Studies published from 2015 to September 2024 were searched in PubMed, Cochrane Library, and Google Scholar. Observational studies and case series on CIED removal and LP implantation were eligible. The primary outcomes were all‐cause mortality and reinfection post‐LP implantation. Pooled estimates were obtained using the Freedman‐Tukey double arcsine transformation. Study quality was assessed using the MINORS criteria, with data extraction and independent assessment by two authors. Results: Of 396 records, 16 studies were included in the analysis, with 653 patients (mean age:76.9 years). The incidence of isolated pocket infections was 46.7% (95% CI: 32.7%–61.2%) and systemic infections at 46.3% (95% CI: 29.5%–64.0%). The primary outcome incidence was 19.4% (95% CI: 12.8%–28.3%, I 2 : 0%) for simultaneous CIED extraction and LP implantation compared with 7.79% (4.37%–13.5%, I 2 : 4%) for LP implantation after CIED extraction ( p = .009). All‐cause mortality rates were 22.8% (95% CI: 15.9%–31.6%, I 2 : 0%) for simultaneous implantation and 8.71% (4.46%–16.3%, I 2 : 21%) after extraction ( p = 0.008). Reinfection was not observed in any of these studies. Conclusion: Simultaneous CIED extraction and LP implantation due to infection may be associated with an increased risk of all‐cause mortality.